. . "11150" . "Nov\u00E9 l\u00E9ky v l\u00E9\u010Db\u011B B-lymfoproliferativn\u00EDch onemocn\u011Bn\u00ED - novinky z ICML kongresu v Luganu, \u010Derven 2013"@cs . "New drugs in the treatment of B-lymphoproliferative disorders - highlights from ICML congress in Lugano, June 2013"@en . . "RIV/00216208:11150/13:10159008!RIV14-MSM-11150___" . "Nov\u00E9 l\u00E9ky v l\u00E9\u010Db\u011B B-lymfoproliferativn\u00EDch onemocn\u011Bn\u00ED - novinky z ICML kongresu v Luganu, \u010Derven 2013" . . "[AEDB46A044E0]" . "Acta medicinae" . . "Speci\u00E1l" . . . . "Traditional haematology congress discussing problems of lymfoprolilefative disordes held in Lugano, June 2013. Many new drugs in the field of lymphoma patients care have been discussed. Three of them are discussed in this article - ibrutinib, idelalisib and ABT-199."@en . "Nov\u00E9 l\u00E9ky v l\u00E9\u010Db\u011B B-lymfoproliferativn\u00EDch onemocn\u011Bn\u00ED - novinky z ICML kongresu v Luganu, \u010Derven 2013"@cs . . "RIV/00216208:11150/13:10159008" . "5"^^ . . "New drugs in the treatment of B-lymphoproliferative disorders - highlights from ICML congress in Lugano, June 2013"@en . . "I, P(NT12193), P(NT13072)" . "1"^^ . "ABT-199; ibrutinib; CLL; lymphoma"@en . "1"^^ . "92220" . "1805-398X" . "Belada, David" . . "CZ - \u010Cesk\u00E1 republika" . "Tradi\u010Dn\u00ED hematologick\u00FD kongres zab\u00FDvaj\u00EDc\u00ED se zejm\u00E9na problematikou lymfoproliferativn\u00EDch onemocn\u011Bn\u00ED se konal po dvou letech v \u010Dervnu 2013, a to op\u011Bt ve \u0161v\u00FDcarsk\u00E9m Luganu. B\u011Bhem kongresu byla p\u0159edstavena cel\u00E1 \u0159ada nov\u00FDch l\u00E9k\u016F, kter\u00E9 jsou ji\u017E ve f\u00E1zi klinick\u00E9ho zkou\u0161en\u00ED, a kter\u00E9 se mohou velmi brzy prosadit na poli l\u00E9\u010Dby lymfom\u016F a CLL. V n\u00E1sleduj\u00EDc\u00EDm sd\u011Blen\u00ED budou diskutov\u00E1ny t\u0159i z nich, kter\u00E9 jsou velkou nad\u011Bj\u00ED pro nemocn\u00E9 s lymfomy a CLL - ibrutinib, idelalisib a ABT-199." . . . . . . "2" . . "Nov\u00E9 l\u00E9ky v l\u00E9\u010Db\u011B B-lymfoproliferativn\u00EDch onemocn\u011Bn\u00ED - novinky z ICML kongresu v Luganu, \u010Derven 2013" . . "Tradi\u010Dn\u00ED hematologick\u00FD kongres zab\u00FDvaj\u00EDc\u00ED se zejm\u00E9na problematikou lymfoproliferativn\u00EDch onemocn\u011Bn\u00ED se konal po dvou letech v \u010Dervnu 2013, a to op\u011Bt ve \u0161v\u00FDcarsk\u00E9m Luganu. B\u011Bhem kongresu byla p\u0159edstavena cel\u00E1 \u0159ada nov\u00FDch l\u00E9k\u016F, kter\u00E9 jsou ji\u017E ve f\u00E1zi klinick\u00E9ho zkou\u0161en\u00ED, a kter\u00E9 se mohou velmi brzy prosadit na poli l\u00E9\u010Dby lymfom\u016F a CLL. V n\u00E1sleduj\u00EDc\u00EDm sd\u011Blen\u00ED budou diskutov\u00E1ny t\u0159i z nich, kter\u00E9 jsou velkou nad\u011Bj\u00ED pro nemocn\u00E9 s lymfomy a CLL - ibrutinib, idelalisib a ABT-199."@cs .